Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy-Reference-Cited by-同舟云学术

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy

Published:2020-05-01 Issue:5 Volume:156 Page:545
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Mignard Claire¹,Maho-Vaillant Maud¹,Golinski Marie-Laure¹,Balayé Pierre²,Prost-Squarcioni Catherine³,Houivet Estelle²,Calbo Sé´bastien¹,Labeille Bruno⁴,Picard-Dahan Catherine⁵,Konstantinou Maria Polina⁶,Chaby Guillaume⁷,Richard Marie-Aleth⁸,Bouaziz Jean-David⁹,Duvert-Lehembre Sophie¹⁰,Delaporte Emmanuel¹⁰,Bernard Philippe¹¹,Caux Frédéric³,Alexandre Marina³,Ingen-Housz-Oro Saskia¹²,Vabres Pierre¹³,Quereux Gaëlle¹⁴,Dupuy Alain¹⁵,Debarbieux Sébastien¹⁶,Avenel-Audran Martine¹⁷,D’Incan Michel¹⁸,Bédane Christophe¹⁹,Bénéton Nathalie²⁰,Jullien Denis²¹,Dupin Nicolas²²,Misery Laurent²³,Machet Laurent²⁴,Beylot-Barry Marie²⁵,Dereure Olivier²⁶,Sassolas Bruno²⁷,Benichou Jacques²,Joly Pascal¹,Hébert Vivien¹,

Affiliation:

1. Centre de référence des maladies bulleuses auto-immunes, Department of Dermatology, Rouen University Hospital, Normandie University, INSERM U1234, Rouen, France

2. Department of Biostatistics and Clinical Research, Rouen University Hospital, Rouen, France

3. Centre de référence des maladies bulleuses auto-immunes, Avicenne Hospital, Assistance Publique–Hôpitaux de Paris, Department of Dermatology, University of Paris 13, Bobigny, France

4. Department of Dermatology, University of Saint Etienne, Saint Etienne, France

5. Department of Dermatology, Bichat Hospital, University of Paris X, Paris, France

6. Department of Dermatology, University of Toulouse, Toulouse, France

7. Department of Dermatology, University of Amiens, Amiens, France

8. Assistance Publique des Hôpitaux de Marseille, Department of Dermatology, Aix Marseille University, UMR 911, INSERM CRO2, Marseille, France

9. Department of Dermatology, St Louis Hospital, Paris 7 Sorbonne Paris Cité University, Paris, France

10. Department of Dermatology, University of Lille, Lille, France

11. Department of Dermatology, University of Reims, Reims, France

12. Department of Dermatology, Assistance Publique–Hôpitaux de Paris, Henri Mondor Hospital, Créteil, France

13. Department of Dermatology, Dijon University Hospital, Dijon, France

14. Department of Dermatology, University of Nantes, Nantes, France

15. Department of Dermatology, University of Rennes, Rennes, France

16. Department of Dermatology, Centre Hospitalier Lyon Sud, Pierre Bénite, Lyon, France

17. Department of Dermatology, University of Angers, Angers, France

18. Department of Dermatology, University of Clermont-Ferrand, Clermont-Ferrand, France

19. Department of Dermatology, University of Limoges, Limoges, France

20. Department of Dermatology, Le Mans General Hospital, Le Mans, France

21. Department of Dermatology, Edouard Herriot Hospital, Lyon Claude Bernard University, Lyon, France

22. Department of Dermatology, University of Paris V, Paris, France

23. Department of Dermatology, Brest University Hospital, Brest, France

24. Department of Dermatology, Tours University Hospital, Tours, France

25. Department of Dermatology, University of Bordeaux, Bordeaux, France

26. Department of Dermatology, University of Montpellier, Montpellier, France

27. Department of Internal Medicine, Brest University Hospital, Brest, France

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2762874/jamadermatology_mignard_2020_oi_200010.pdf

Reference36 articles.

1. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion.;Amagai;Cell,1991

2. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.;Stanley;J Clin Invest,1989

3. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease.;Anhalt;N Engl J Med,1982

4. Bullous pemphigoid and pemphigus vulgaris—incidence and mortality in the UK: population based cohort study.;Langan;BMJ,2008

5. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome.;Stanley;N Engl J Med,2006

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris;International Journal of Dermatology;2024-07-31

2. Evolution of rituximab use over time in moderate-to-severe pemphigus: A two-centre retrospective study;Annales de Dermatologie et de Vénéréologie;2024-06

3. Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients;Annales de Dermatologie et de Vénéréologie;2024-06

4. Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy;JAMA Dermatology;2024-03-01

5. Integrative single-cell analysis reveals distinct adaptive immune signatures in the cutaneous lesions of pemphigus;Journal of Autoimmunity;2024-01